Circulating Short-Chain Fatty Acids and Non-Alcoholic Fatty Liver Disease Severity in Patients with Type 2 Diabetes Mellitus
Nutrients · 2023
DOI: 10.3390/nu15071712 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Hui-Ju Tsai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung 801, Taiwan. Hauptthemen laut MEDLINE: Fatty Acids, Volatile, Non-alcoholic Fatty Liver Disease, Diabetes Mellitus, Type 2, Fatty Liver. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kaohsiung Municipal Ta-Tung Hospital, National Pingtung University of Science and Technology and Kaohsiung Medical University.
Themen: Diabetes mellitus
Abstract (Originalsprache)
(1)
Background
Non-alcoholic fatty liver disease (NAFLD) is a major global health concern. The increasing prevalence of NAFLD has been related to type 2 diabetes mellitus (T2D). However, the relationship between short-chain fatty acids (SCFAs) and NAFLD severity is ambiguous in T2D subjects. This study aimed to explore the association of SCFAs with the severity of NAFLD in T2D patients. (2)
Methods
We employed echography to examine the severity of hepatic steatosis. The serum levels of nine SCFAs, namely, formate, acetate, propionate, butyrate, isobutyrate, methylbutyrate, valerate, isovalerate, and methylvalerate, were measured using gas chromatography mass spectrometry. (3)
Results
A total of 259 T2D patients was enrolled in this cross-sectional study. Of these participants, 117 with moderate to severe NAFLD had lower levels of formate, isobutyrate, and methylbutyrate than the 142 without NAFLD or with mild NAFLD. Lower circulating levels of isobutyrate and methylbutyrate were associated with an increased severity of NAFLD. A relationship between NAFLD severity and circulating isobutyrate and methylbutyrate levels was found independently of a glycated hemoglobin (HbA1C) level of 7.0%. (4)
Conclusion
Circulating levels of isobutyrate and methylbutyrate were significantly and negatively correlated with NAFLD severity in the enrolled T2D patients. SCFAs may be related to NAFLD severity in T2D patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Family Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung 801, Taiwan.
- Department of Family Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
- Department of Family Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
- Research Center for Precision Environmental Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
- Department of Microbiology and Immunology, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
- Division of Endocrinology and Metabolism, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.
ORCID-Profile: Hui-Ju Tsai, Yo-Chia Chen, Chun-Ying Lee, Yi-Chun Tsai, Chia-Yen Dai
Förderung
- Kaohsiung Municipal Ta-Tung Hospital
- National Pingtung University of Science and Technology and Kaohsiung Medical University
Zitieren
APA
Tsai, H. J., Hung, W. C., Hung, W. W., Lee, Y. J., Chen, Y. C., Lee, C. Y., Tsai, Y. C., & Dai, C. Y. (2023). Circulating Short-Chain Fatty Acids and Non-Alcoholic Fatty Liver Disease Severity in Patients with Type 2 Diabetes Mellitus. Nutrients. https://doi.org/10.3390/nu15071712
Vancouver
Tsai HJ, Hung WC, Hung WW, Lee YJ, Chen YC, Lee CY, et al. Circulating Short-Chain Fatty Acids and Non-Alcoholic Fatty Liver Disease Severity in Patients with Type 2 Diabetes Mellitus. Nutrients. 2023. doi:10.3390/nu15071712
BibTeX
@article{Tsai2023,
author = {Tsai, Hui-Ju and Hung, Wei-Chun and Hung, Wei-Wen and Lee, Yen-Jung and Chen, Yo-Chia and Lee, Chun-Ying and Tsai, Yi-Chun and Dai, Chia-Yen},
title = {Circulating Short-Chain Fatty Acids and Non-Alcoholic Fatty Liver Disease Severity in Patients with Type 2 Diabetes Mellitus},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu15071712}
}
EUVIMED